- Valepotriate
-
- $75.00
-
2026-04-22
- CAS:18296-44-1
- Purity: 99.90%
- Supply Ability: 10g
- Valepotriate
-
-
2023-02-24
- CAS:18296-44-1
- Min. Order: 5mg
- Purity: ≥98%(HPLC)
- Supply Ability: 10 g
- Valtrate
-
- $1.00
-
2019-07-06
- CAS:18296-44-1
- Min. Order: 1g
- Purity: 99%
- Supply Ability: 100KG
|
| | Valtrate Basic information |
| Product Name: | Valtrate | | Synonyms: | HalazuchroMe B;ValepotriatuM;ValtratuM;VALTRATE(P);[(1S,6S,7aS)-4-(Acetyloxymethyl)-1-(3-methylbutanoyloxy)spiro[6,7a-dihydro-1H-cyclopenta[c]pyran-7,2'-oxirane]-6-yl] 3-methylbutanoate;Valtrate;(1S,7R)-4-Acetoxymethyl-6,7aα-dihydrospiro[cyclopenta[c]pyran-7(1H),2'-oxirane]-1α,6α-diol 1,6-bis(3-methylbutanoate);VALTRATE(P)(PLEASE CALL) | | CAS: | 18296-44-1 | | MF: | C22H30O8 | | MW: | 422.47 | | EINECS: | 242-174-2 | | Product Categories: | Miscellaneous Natural Products | | Mol File: | 18296-44-1.mol |  |
| | Valtrate Chemical Properties |
| Boiling point | 525.9±50.0 °C(Predicted) | | density | 1.22±0.1 g/cm3(Predicted) | | storage temp. | Refrigerator | | solubility | Chloroform (Slightly, Sonicated), Methanol (Slightly) | | form | Oil | | color | Pale Brown to Dark Yellow | | Water Solubility | slightly soluble in water | | InChIKey | BDIAUFOIMFAIPU-KVJIRVJXSA-N | | SMILES | CC(C)CC(O[C@H](OC=C1COC(C)=O)[C@@]2([H])C1=C[C@H](OC(CC(C)C)=O)[C@@]23OC3)=O |
| WGK Germany | WGK 3 | | HS Code | 29329990 | | Storage Class | 11 - Combustible Solids |
| | Valtrate Usage And Synthesis |
| Chemical Properties | Yellow liquid, soluble in organic solvents such as methanol, ethanol, DMSO, etc., derived from spider lily and valerian. | | Uses | Valtrate is a Rev-transport inhibitor with anti-HIV activity from Valerianae Radix. | | Definition | ChEBI: Valtratum is a fatty acid ester. | | in vivo | Valepotriateshowed significant anti-epileptic activity against MES- and PTZ-induced epilepsy at doses of 5, 10, and 20 mg/kg, and ED50values for MES- and PTZ-induced epilepsy were 7.84 and 7.19 mg/kg, respectively. Furthermore,valepotriate(10 and 20 mg/kg) can significantly prolong sleeping time and shorten the latency time on the pentobarbital sodium-induced sleeping time test. Furthermore,valepotriate(5, 10, and 20 mg/kg) could significantly up-regulate the expression of GABAA, GAD65, and Bcl-2 and down-regulate the expression of caspase-3, but had no significant effect on the expression of GABAB[2]. |
| | Valtrate Preparation Products And Raw materials |
|